Schraier M, Jorge A, Pereyra J C, Carri J, Padua-Videla M, Hoffenberg P, Villalobos J, Orillac J, Waserstein M, Mendoza S
Acta Gastroenterol Latinoam. 1993;23(1):13-7.
394 patients with endoscopically diagnosed duodenal ulcer were randomly allocated to treatment with ranitidine 150 bid o ranitidine 300 mg bid in a prospective double-blind multicenter trial conducted in seven LatinoAmerican countries. Endoscopy at 4 weeks showed complete ulcer healing en 171 of 196 patients (87.2%) treated with ranitidine 150 mg bid and 178 of 198 (89.9%) treated with ranitidine 300 mg bid. Both treatment regimens were equally effective at rapidly reducing the incidence of ulcer-related symptoms. It is possible that higher dosage regimen of ranitidine would be useful in patients with more severe duodenal ulcer disease.
在七个拉丁美洲国家进行的一项前瞻性双盲多中心试验中,394例经内镜诊断为十二指肠溃疡的患者被随机分配接受雷尼替丁150毫克每日两次或雷尼替丁300毫克每日两次的治疗。4周时的内镜检查显示,接受雷尼替丁150毫克每日两次治疗的196例患者中有171例(87.2%)溃疡完全愈合,接受雷尼替丁300毫克每日两次治疗的198例患者中有178例(89.9%)溃疡完全愈合。两种治疗方案在迅速降低溃疡相关症状的发生率方面同样有效。雷尼替丁更高剂量方案可能对更严重的十二指肠溃疡疾病患者有用。